Clinical trial
Bumetanide vs. Furosemide for Adults Hospitalized With Cirrhosis: the BUFF Trial
NCT06941415 is registered in ClinicalTrials.gov with Stacy Johnson as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bumetanide vs. Furosemide for Adults Hospitalized With Cirrhosis: the BUFF Trial
- Lead sponsor
- Stacy Johnson
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- June 3, 2026
- Completion date
- March 31, 2029
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cirrhosis